139 related articles for article (PubMed ID: 35716171)
1. Infantile metastatic ependymoma with a novel molecular profile and favorable outcome to intensive chemotherapy without irradiation: Case-based review.
De Faria FW; Schieffer KM; Pierson CR; Boue DR; LaHaye S; Miller KE; Amayiri N; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly B; White P; Magrini V; Wilson RK; Mardis ER; Cottrell CE; Rusin J; Finlay JL; Osorio DS
Genes Chromosomes Cancer; 2023 Jan; 62(1):39-46. PubMed ID: 35716171
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
3. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
[TBL] [Abstract][Full Text] [Related]
4. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S; Levy A; Chi SN; Gardner S; Rosenblum M; Miller DC; Dunkel I; Diez B; Sposto R; Ji L; Asgharzadeh S; Hukin J; Belasco J; Dubowy R; Kellie S; Termuhlen A; Finlay J
Pediatr Blood Cancer; 2007 Jul; 49(1):34-40. PubMed ID: 16874765
[TBL] [Abstract][Full Text] [Related]
5. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
Grundy RG; Wilne SA; Weston CL; Robinson K; Lashford LS; Ironside J; Cox T; Chong WK; Campbell RH; Bailey CC; Gattamaneni R; Picton S; Thorpe N; Mallucci C; English MW; Punt JA; Walker DA; Ellison DW; Machin D;
Lancet Oncol; 2007 Aug; 8(8):696-705. PubMed ID: 17644039
[TBL] [Abstract][Full Text] [Related]
6. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL
J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673
[TBL] [Abstract][Full Text] [Related]
7. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
Grill J; Le Deley MC; Gambarelli D; Raquin MA; Couanet D; Pierre-Kahn A; Habrand JL; Doz F; Frappaz D; Gentet JC; Edan C; Chastagner P; Kalifa C;
J Clin Oncol; 2001 Mar; 19(5):1288-96. PubMed ID: 11230470
[TBL] [Abstract][Full Text] [Related]
8. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study.
Grill J; Kalifa C; Doz F; Schoepfer C; Sainte-Rose C; Couanet D; Terrier-Lacombe MJ; Valteau-Couanet D; Hartmann O
Pediatr Neurosurg; 1996 Jul; 25(1):7-12. PubMed ID: 9055328
[TBL] [Abstract][Full Text] [Related]
9. Childhood ependymoma: a systematic review of treatment options and strategies.
Grill J; Pascal C; Chantal K
Paediatr Drugs; 2003; 5(8):533-43. PubMed ID: 12895136
[TBL] [Abstract][Full Text] [Related]
10. [Interdisciplinary therapy of childhood ependymomas].
Timmermann B; Kortmann RD; Kühl J; Willich N; Bamberg M
Strahlenther Onkol; 2002 Sep; 178(9):469-79. PubMed ID: 12426832
[TBL] [Abstract][Full Text] [Related]
11. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
12. Ependymoma: Evaluation and Management Updates.
Rudà R; Bruno F; Pellerino A; Soffietti R
Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
[TBL] [Abstract][Full Text] [Related]
13. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
[TBL] [Abstract][Full Text] [Related]
14. Ependymoma in children and young adults (0-19 years): report of 25 consecutive cases.
Helseth E; Due-Tønnessen B; Lote K; Skullerud K; Storm-Mathisen I; Wesenberg F; Lundar T
Childs Nerv Syst; 2001 Jan; 17(1-2):24-30. PubMed ID: 11219619
[TBL] [Abstract][Full Text] [Related]
15. Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG).
White L; Johnston H; Jones R; Mameghan H; Nayanar V; McWhirter W; Kellie S; Waters K; Toogood I
Cancer Chemother Pharmacol; 1993; 32(5):403-6. PubMed ID: 8339393
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy in recurrent ependymoma.
Siffert J; Allen JC
Pediatr Neurosurg; 1998 Jun; 28(6):314-9. PubMed ID: 9782208
[TBL] [Abstract][Full Text] [Related]
17. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.
Strother DR; Lafay-Cousin L; Boyett JM; Burger P; Aronin P; Constine L; Duffner P; Kocak M; Kun LE; Horowitz ME; Gajjar A
Neuro Oncol; 2014 Mar; 16(3):457-65. PubMed ID: 24335695
[TBL] [Abstract][Full Text] [Related]
18. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Needle MN; Goldwein JW; Grass J; Cnaan A; Bergman I; Molloy P; Sutton L; Zhao H; Garvin JH; Phillips PC
Cancer; 1997 Jul; 80(2):341-7. PubMed ID: 9217048
[TBL] [Abstract][Full Text] [Related]
20. Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
Venkatramani R; Ji L; Lasky J; Haley K; Judkins A; Zhou S; Sposto R; Olshefski R; Garvin J; Tekautz T; Kennedy G; Rassekh SR; Moore T; Gardner S; Allen J; Shore R; Moertel C; Atlas M; Dhall G; Finlay J
J Neurooncol; 2013 Jun; 113(2):285-91. PubMed ID: 23508296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
